ABSTRACT
Background: The majority of diabetic cats in remission have abnormal glucose tolerance, and approximately one third relapse within 1 year. Greater understanding of the metabolic characteristics of diabetic cats in remission, and predictors of relapse is required to effectively monitor and manage these cats. Objectives: To identify and compare differences in plasma metabolites between diabetic cats in remission and healthy control cats using a metabolomics approach. Secondly, to assess whether identified metabolites are predictors of diabetic relapse. Animals: Twenty cats in diabetic remission for a median of 101 days, and 22 healthy matched control cats. Methods: Cats were admitted to a clinic, and casual blood glucose was recorded. After a 24 h fast, blood glucose concentration was measured, then a blood sample was taken for metabolomic (GCMS and LCMS) analyses. Three hours later, a simplified intravenous glucose tolerance test (1 g glucose/kg) was performed. Cats were monitored for diabetes relapse for at least 9 months (270 days) after baseline testing. Results: Most cats in remission continued to display impaired glucose tolerance. Concentrations of 16 identified metabolites differed (P ≤ 0.05) between remission and control cats: 10 amino acids and stearic acid (all lower in remission cats), and glucose, glycine, xylitol, urea and carnitine (all higher in remission cats). Moderately close correlations were found between these 16 metabolites and variables assessing glycaemic responses (most |r| = 0.31 to 0.69). Five cats in remission relapsed during the study period. No metabolite was identified as a predictor of relapse. Conclusion and clinical importance: This study shows that cats in diabetic remission have abnormal metabolism.
ABSTRACT
This retrospective study of cat admissions to RSPCA Queensland shelters describes changes associated with improved outcomes ending in live release in 2016 compared to 2011. There were 13,911 cat admissions in 2011 and 13,220 in 2016, with approximately 50% in both years admitted as strays from the general public or council contracts. In contrast, owner surrenders halved from 30% to 15% of admissions. Percentages of admissions ending in euthanasia decreased from 58% to 15%. Only 5% of cat admissions were reclaimed in each of these years, but the percentage rehomed increased from 34% to 74%, of which 61% of the increase was contributed by in-shelter adoptions and 39% from non-shelter sites, predominately retail partnerships. The percentage temporarily fostered until rehoming doubled. In 2011, euthanasias were most common for medical (32% of all euthanasias), behavioral (36%) and age/shelter number (30%) reasons, whereas in 2016, 69% of euthanasias were for medical reasons. The number of young kittens euthanized decreased from 1116 in 2011 to 22 in 2016. The number of cats classified as feral and euthanized decreased from 1178 to 132, in association with increased time for assessment of behavior and increased use of behavior modification programs and foster care. We attribute the improved cat outcomes to strategies that increased adoptions and reduced euthanasia of young kittens and poorly socialized cats, including foster programs. To achieve further decreases in euthanasia, strategies to decrease intake would be highly beneficial, such as those targeted to reduce stray cat admissions.
